POLB — Poolbeg Pharma Cashflow Statement
0.000.00%
Last trade - 00:00- £53.00m
- £38.88m
Annual cashflow statement for Poolbeg Pharma, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | |
|---|---|---|
| Period Length: | 12 M | 12 M |
| Source: | ARS | ARS |
| Standards: | IFRS | IFRS |
| Status: | Final | Final |
| Net Income/Starting Line | -2.34 | -4.78 |
| Amortisation | ||
| Non-Cash Items | 0.24 | 0.22 |
| Other Non-Cash Items | ||
| Changes in Working Capital | -0.068 | 0.163 |
| Change in Accounts Receivable | ||
| Change in Payable / Accrued Expenses | ||
| Other Operating Cash Flow | ||
| Cash from Operating Activities | -2.15 | -4.37 |
| Capital Expenditures | -0.081 | -0.597 |
| Purchase / Acquisition of Intangibles | ||
| Other Investing Cash Flow Items | — | 0.209 |
| Other Investing Cash Flow | ||
| Cash from Investing Activities | -0.081 | -0.388 |
| Net Issuance / Retirement of Stock | ||
| Net Issuance / Retirement of Debt | ||
| Cash from Financing Activities | 23.2 | 0 |
| Beginning Cash Balance | ||
| Ending Cash Balance | ||
| Net Change in Cash | 20.9 | -4.76 |